+ dendritic cells (DCs) and induced production of the T H 2-attracting chemokines TARC (thymus and activation-regulated chemokine; also known as CCL17) and MDC (macrophage-derived chemokine; CCL22).TSLP-activated DCs primed naïve T H cells to produce the proallergic cytokines interleukin 4 (IL-4), IL-5, IL-13 and tumor necrosis factor-α, while downregulating IL-10 and interferon-γ. TSLP was highly expressed by epithelial cells, especially keratinocytes from patients with atopic dermatitis.TSLP expression was associated with Langerhans cell migration and activation in situ.These findings shed new light on the function of human TSLP and the role played by epithelial cells and DCs in initiating allergic inflammation. 
Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP
About 20% of the population in Western countries suffers from allergic diseases, which include asthma, allergic rhinitis, atopic dermatitis and food allergy 1 . Allergic inflammation is the result of a complex immunological cascade that leads to dysregulated production of T helper type 2 (TH2)-derived cytokines such as interleukin 4 (IL-4), IL-5 and IL-13 [2] [3] [4] , which trigger immunoglobulin E (IgE) production, eosinophilia and mucus production [5] [6] [7] . Dendritic cells (DCs), which are professional antigen-presenting cells 8 , play an important role in the pathogenesis of allergic diseases [9] [10] [11] . However, the initial signal that primes DCs to induce T cells to produce proallergic TH2 cytokines is unknown. Epithelial cells are located at the sites of allergen entry into the body and interact closely with DCs in situ. However, it is not known whether DCs play a role in triggering the allergic immune cascade. Although skin keratinocytes and mucosal epithelial cells produce proinflammatory cytokines such as IL-1, IL-6, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-α (TNF-α) after activation 12 , none of these cytokines explain the mechanism that underlies the induction of allergic inflammation.
Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine, cloned from a murine thymic stromal cell line 13 . The TLSP receptor is a heterodimer that consists of the IL-7 receptor α chain (IL-7Rα) and a common γ-like receptor chain called TSLP receptor (TSLPR) [14] [15] [16] [17] . Mouse TSLP supports murine early B and T cell developments 18, 19 and does not appear to have any biological effects on murine DCs (unpublished data). In contrast, human TSLP activates CD11c + DCs, but does not appear to have any direct biological effects on B cells, T cells, NK cells, neutrophils or mast cells 17 . This is in accordance with the coexpression of IL-7Rα chain and TSLPR mRNA in CD11c + DCs, but not in other cell types. We show here that human TSLP potently activated human CD11c + DCs, which subsequently primed naïve TH cells to produce high concentrations of IL-13, IL-5 and TNF-α, moderate amounts of IL-4 and down-regulate IL-10 and interferon-γ (IFN-γ). TSLP is highly expressed by epithelial cells of inflamed tonsils and keratinocytes of atopic dermatitis. Thus, TSLP represents a key epithelial cell or keratinocyte-derived cytokine that directly triggers DC-mediated allergic inflammation.
Results

TSLP potently activates human CD11c + DCs
We compared the effects of TSLP, IL-7, CD40 ligand (CD40L)and lipopolysaccharide (LPS) on human CD11c + DC activation. TSLP, IL-7, CD40L and LPS all up-regulated surface HLA-DR, CD40, CD80, CD86 and CD83 on DCs when compared with medium alone (Fig. 1a) . Whereas TSLP induced the most CD40 and CD80 expression on DCs, CD40L induced more HLA-DR and CD83. Like CD40L, TSLP not only activated DCs, but also maintained the survival of DCs in 24-h cultures, as shown by annexin V staining (Fig. 1a) and cell counts (data not shown).
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The ability of TSLP to up-regulate HLA-DR and costimulatory molecules was blocked by two neutralizing monoclonal antibodies (mAbs)-5E5 and 12F3-that were specific for human TSLP (Fig. 1b) . The two TSLP mAbs did not block the up-regulation of HLA-DR and costimulatory molecules on DCs induced by CD40L, IL-7 or LPS (data not shown). These data indicated that the observed effects of TSLP on CD11c + DCs were TSLP-specific. Morphologically, both TSLP-activated DCs (referred to hereafter as TSLP-DCs) and CD40L-activated DCs (referred to hereafter as CD40L-DCs) showed long dendrites and expressed more HLA-DR and DC-lysosome-associated membrane protein (DC-LAMP, which is a DC activation marker) compared to DCs in medium alone or IL-7-activated DCs (referred to hereafter as IL-7-DCs) (Fig. 1c) .
TSLP-DCs induce CD4 + T cell expansion
Compared to CD40L-DCs, LPS-activated DCs (referred to hereafter as LPS-DCs) or IL-7-DCs, TSLP-DCs induced stronger naïve CD4 + T cell proliferation in an allogeneic mixed lymphocyte reaction (Fig. 2a) . At a 1:150 ratio of DCs:T cells, TSLP-DCs still induced allogeneic naïve CD4 + T cell proliferation that was about three-times stronger than that induced by CD40L-DCs (Fig. 2a) . After 6 days of culture, TSLPDCs induced a 7.5-to 9-fold increase in total T cell numbers, which was more than that induced by CD40L-DCs, LPS-DCs or IL-7-DCs (Fig. 2b) . Therefore, human TSLP represents one of the most potent DC activation factors, and TSLP-DCs induce the most marked allogeneic naïve CD4 + T cell proliferation and expansion. 
TSLP-DCs induce T H 2 development
Most DC activation signals, such as CD40L and LPS, induce DCs to produce the proinflammatory cytokines IL-1α/β, IL-6 and IL-12 20, 21 and prime naïve CD4 + T cell differentiation towards TH1 [22] [23] [24] . We performed a global quantitative mRNA screening of 11 different cytokines-IL-1α, IL-1β, IL-4, IL-6, IL-10, IL-12p35, IL-12p40, IL-13, IL-18, IL-23p19 and TNF-α-and 12 different chemokines-thymus and activation-regulated chemokine (TARC also known as CCL17), DCCK1, macrophage-derived chemokine (MDC or CCL22), monocyte chemoattractant protein 1 (MCP-1 or CCL2), MCP-2 (or CCL8), MCP-3 (or CCL7), MCP-4 (or CCL13), eotaxin (or CCL11), macrophage inflammatory protein (MIP-3β or CCL19), monokine induced by γ interferon (MIG or CXCL9), RANTES (or CCL5) and IL-8 (or CXCL8)-which have potential effects either on naïve CD4 + T cell polarization or the migration of TH1 or TH2 cells. Unlike CD40L-DCs and LPS-DCs, TSLP-DCs did not produce mRNA for all the proinflammatory cytokines tested, but did produce high levels of mRNA for the chemokines TARC and MDC (data not shown). Enzyme-linked immunosorbent assay (ELISA) analyses confirmed at the protein level that TLSP-DCs did not produce detectable amounts of the proinflammatory cytokines IL-1β, IL-6, IL-12p70 and TNF-α, but did produce high amounts of the chemokines TARC and MDC (Fig. 3) . TARC and MDC preferentially attract CCR4-expressing TH2 cells 25 . The capacity of TSLP-DCs to polarize naïve CD4 + T cells was compared to DCs cultured with medium, IL-7, CD40L or LPS. Naïve human CD4 + CD45RA + T cells purified from adult peripheral blood were cultured with DCs at a 1:5 ratio for 6 days; they were then washed to remove all cytokines, restimulated for 24 h with anti-CD3 and anti-CD28 and then cytokine production was measured in the culture supernatant by ELISA. TSLP-DCs induce naïve CD4 + T cells to produce large amounts of IL-13, IL-5 and TNF-α and a moderate amount of IL-4 ( . In addition, TSLP-DCs may further enhance TH2-mediated inflammation by producing chemokines such as TARC and MDC, which may preferentially recruit TH2 cells into the original inflamed tissues [28] [29] [30] . 
675
TSLP protein expression by epithelial cells
Human tonsils contain two types of epithelium: crypt epithelium, which frequently harbors viruses and bacteria and represents the site of antigenentry and constitutive inflammation, and squamous epithelium. Using the mAb 12F3, we showed that TSLP is expressed by crypt epithelial cells, which were in close contact with cells expressing DC-LAMP in five different tonsillar samples tested 31 (Fig. 6) . In all tonsil samples tested, only a few small foci of TSLP expression were found within the apical part of the squamous epithelium (Fig. 7) . The expression of TSLP was associated with the infiltration of DC-LAMP + -activated DCs (Fig. 7a,b ) and the concurrent loss of langerin + Langerhans cells within the squamous epithelium (Fig. 7c,d ). Staining with 12F3 was specific for TSLP because recombinant TSLP, but not IL-7, completely blocked the staining and rat Ig isotype control antibody did not give any positive staining (data not shown). These results suggested that TSLP may contribute to constitutive inflammation within the crypt epithelium and sporadic inflammation within the squamous epithelium.
High TSLP expression in atopic dermatitis
To investigate whether TSLP expression is associated with TH2-type allergic inflammation in vivo, TSLP protein expression was analyzed in skin lesions, including atopic dermatitis (a TH2-mediated allergic disease), nickel-induced contact dermatitis (an IFN-γ-producing T cell-mediated allergic disease) and cutaneous lupus erythematosus samples. Although TSLP was undetectable in normal skin (11 separate samples) (Fig. 8a) , high expression of TSLP was found in the keratinocytes of acute (ten patients, Fig. 8b,c) and chronic atopic dermatitis (five patients, Fig. 8d-f) . Isotype control-staining of an adjacent section (as shown in Fig. 8d ) gave a negative result. Expression of TSLP was found mainly in keratinocytes of the apical layers of the epidermis, which ranged from small foci to the whole apical areas in both acute and chronic atopic dermatitis. The characteristics of these patients with atopic dermatitis are summarized ( Table 1 ). 
a b
Nonlesional skin samples were available for 9 of 15 atopic dermatitis patients. None of these samples stained positive for TSLP, which confirmed the specificity of TSLP for atopic dermatitis lesions and its absence from normal skin. Using Fisher's exact test, we were able to show that the difference between the normal skin group and atopic dermatitis group was statistically significant (P < 0.001). TSLP was not found in skin lesions from nickel-induced allergy contact dermatitis (Fig. 8h) or cutaneous lupus erythematosus (Fig. 8i) patients.
TSLP associates with Langerhans cell activation
To investigate whether TSLP expression in atopic dermatitis is associated with DC activation, TSLP was stained together with either langerin (the Langerhans cell marker) or DC-LAMP (the DC activation marker) in double immunohistology experiments (Fig. 9) . In normal skin, or nonlesional skin of from atopic dermatitis samples, many langerin + Langerhans cells were found within the epidermis, but not within the dermis (Fig. 9a) ; and no DC-LAMP + activated DCs were found in either the epidermis or the dermis (Fig. 9b) . Strong TSLP expression in atopic dermatitis was associated with the disappearance of langerin 
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Langerhans cells within the epidermis (Fig. 9c) and the concurrent appearance of many DC-LAMP + activated DCs within the dermis (Fig. 9d) . Many of the DC-LAMP + activated DCs within the dermis expressed langerin, suggesting that epidermal Langerhans cells may be activated and migrate into the dermis (Fig. 9d) . These results suggested that TSLP expression by keratinocytes in atopic dermatitis lesions may contribute directly to the activation of Langerhans cells, which may then migrate into the draining lymph nodes and prime allergen-specific TH2 responses.
Discussion
We have shown here that the epithelial cells of skin and mucosa may directly interact with DCs during allergic inflammation by producing TSLP. Human TSLP is a DC activator that displays several unique features compared with other DC activation factors, such as CD40L, LPS or IL-7. It induced more CD40 and CD80 expression on DCs compared to other activators, activated DCs to induce strong naïve CD4 + T cell proliferation and expansion, did not induce DCs to produce proinflammatory cytokines (instead it produced the TH2-attracting chemokines TARC and MDC) and it endowed DCs with the ability to prime naïve CD4 + T cells to produce large amounts of IL-13, IL-5 and TNF-α and moderate amounts of IL-4. However, expression of the anti-inflammatory cytokine IL-10 and the TH1 cytokine IFN-γ were inhibited. These features suggested that TSLP represents a critical mediator in uncontrolled allergic inflammation.
Activation of DCs appears to be a critical step in the pathogenesis of TH2-mediated allergic inflammation. Although DCs from allergic individuals preferentially induce a TH2-type response [32] [33] [34] [35] [36] , the molecular mechanism underlying the signaling of DCs to induce TH2 allergic diseases is not understood. Our findings that TSLP is highly expressed by keratinocytes of atopic dermatitis and TSLP-DCs strongly prime naïve CD4 + T cells to produce IL-13, IL-5 and TNF-α suggest that TSLP likely represents the missing critical factor, which is key to understanding the pathogenesis of allergic diseases. TSLP produced by epithelial cells, or other stromal cells at the site of antigen entry, may activate DCs and stimulate them to produce TH2-attracting chemokines such as TARC and MDC. Migration of TSLP-DCs to the draining lymph nodes would induce allergen-specific T cell proliferation and differentiation into TH2 cells. These allergen-specific TH2 T cells may then migrate back towards TARC and MDC, within the original site of inflammation, to trigger allergic inflammation. Indeed, T cell infiltration was found in skin samples from all the atopic derematitis patients tested in another study 37 . In addition, skin-homing T cells from atopic dermatitis produce TH2 cytokines 38 . Therefore, our work provides a direct functional link between epithelial cells, DCs and T cell-mediated immune responses.
Unlike classical TH2 cells, which produce IL-4, IL-5, IL-10 and IL-13, human CD4 + T cells primed with TSLP-DCs produce high IL-13 and IL-5, moderate IL-4 but little IL-10. Although, historically, IL-10 has been included as a TH2 cytokine 27 , its contribution to the TH2-mediated allergic inflammation has been controversial. Some studies showed that IL-10 mRNA levels in the lung, gut and skin were increased in patients with allergic asthma or atopic dermatitis 39 . However, direct measurement of IL-10 protein by ELISA showed markedly lower amounts of IL-10 in the bronchealveolar lavage or in the culture supernatants of activated peripheral blood mononuclear cells from atopic patients compared to normal control subjects 40 . Studies in mouse models confirm a role for IL-10 in suppressing airway inflammation and cytokine production 41, 42 . Therefore, high concentrations of IL-13, IL-5 and TNF-α, moderate amounts of IL-4 and decreased production of IL-10 and IFN-γ by TSLP-DCs activated T cells and may represent the real allergic inflammatory cytokines that underlie the pathophysiology of atopic dermatitis or asthma.
Historically, the study of allergic diseases has been focused on the effector cells, such as mast cells and eosinophils. TH2 cells and DCs are implicated as playing key roles in the upstream steps of allergic inflammation. Our study indicates that epithelial cells may well provide the initial trigger of the allergic immune cascade. Epithelial cell-derived TSLP not only potently activates DCs, but also endows DCs with the ability to polarize naïve T cells to produce proallergic TH2 cytokines. TSLP may represent a new target to block inflammatory diseases, in particular allergic diseases. T cell cytokine production. After 6 days of coculture, DC-primed CD4 + T cells were restimulated for 24 h with plate-bound anti-CD3 (10 µg/ml) and soluble anti-CD28 (2 ng/ml). Cytokine production was assessed in the culture supernatant by protein ELISA for IL-4, IL-5, IL-10, IL-13, TNF-α and IFN-γ (all from R&D Systems). For intracellular cytokine production, T cells were collected on day 6 of the culture, washed twice and restimulated with PMA + ionomycin in flat-bottomed 96-or 48-well plates at a concentration of 1 × 10 6 /ml. After 2.5 h, brefeldin A was added at 10 mg/ml. After 5 h, cells were collected, fixed with 2% formaldehyde, permeabilized with 10% saponin and stained with PE-conjugated mAbs to IL-4, IL-5, IL-10, IL-13 and ΤΝF-α and FITC-conjugated anti-IFN-γ (all from Pharmingen). Stained cells were analyzed on a FACScan flow cytometer (Becton Dickinson). 17 . Results are expressed as mRNA levels relative to ubiquitin.
Methods
Skin biopsy samples. After obtaining informed consent from patients, 3-6 mm punch biopsies were taken from either lesional or nonlesional skin from atopic dermatitis (n = 15) or disseminated lupus erythematosus patients (n = 5) or from normal healthy individuals (n = 11). Patients with a history of allergic contact dermatitis against nickel (n = 8) underwent diagnostic nickel patch tests, and skin biopsies (three per patient) were taken before and 6, 24 or 48 h after allergen exposure. Skin samples were immediately frozen in liquid nitrogen and stored at -80 °C. The study was approved by the local ethics committees of the Department of Medicine of the Helsinki-Uusimaa Hospital District, Finland and the Heinrich-Heine University, Dusseldorf, Germany.
Immunohistology. Frozen sections (8 µm) of human tonsil or skin were incubated with rat anti-human TSLP (mAb 12F3, DNAX, Palo Alto, CA) at room temperature for 1 h in PBS. The slides were washed with PBS twice and incubated with biotinylated secondary antibody for 30 min (PK-4004, Vector Laboratories, Burlingame, CA). The slides were washed and incubated with avidin-peroxidase complex reagents for 30 min (PK-4004, Vector Laboratories). The slides were washed and incubated with substrate SK-4200, which stained red (Vector Laboratories). For double staining of human TSLP with DC-LAMP or langerin, the slides were incubated with mouse anti-human DC-LAMP (IM3448) or mouse anti-human langerin (IM3449, Immunotech, Marseille, France) for 1 h; this was followed by red anti-TSLP staining. The slides were washed and incubated with biotinylated anti-mouse Ig (AK-5002, Vector Laboratories), then the avidin-peroxidase complex reagents (AK-5002, Vector Laboratories) for 30 min each. The slides were washed and the incubated with the substrate SK-5300, which stained blue (Vector Laboratories).
